Compounds > paclitaxel
Page last updated: 2024-08-23

paclitaxel and iloprost

paclitaxel has been researched along with iloprost in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Alt, E; Baur, R; Hähnel, I; Hannekum, A; Hemmer, W; Herter, T; Hombach, V; Resch, A; Seliger, C; Stemberger, A; Voisard, R1

Other Studies

3 other study(ies) available for paclitaxel and iloprost

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Triple-coated stents (Hirudin/Iloprost/Paclitaxel): an in vitro approach for characterizing the antiproliferative potential of each individual compound.
    International journal of cardiology, 2005, Jul-20, Volume: 102, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Cell Proliferation; Coronary Artery Bypass; Coronary Restenosis; Drug Combinations; Drug Delivery Systems; Fibrinolytic Agents; Hirudins; Humans; Iloprost; In Vitro Techniques; Paclitaxel; Platelet Aggregation Inhibitors; Stents

2005